Gilead Sciences, a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines, has appointed Houbara Communications as its official public relations and communications partner in the GCC.
This collaboration marks a significant milestone for both companies and underscores their commitment to advancing healthcare communication in the region.
“At Gilead Sciences, we view ourselves as a partner to government, medical, and industry stakeholders across the Middle East, working collaboratively to achieve healthcare goals and create a healthier world for all,” said Alexey Brevnov, Public Affairs Director Middle East at Gilead.
“In this journey, we are confident that Houbara Communications is the right partner to develop and tell our story across key markets, and I look forward to working closely with the team to achieve this.”
Houbara Communications claims to take an entrepreneurial approach to all aspects of its client service.
To add to the pride of partnering with Gilead, Loretta Ahmed, CEO of Houbara Communications. said, “As a leading biopharmaceutical company, dedicated to improving patient outcomes, Gilead’s work aligns perfectly with our agency’s mission to drive positive change through strategic communication.”
“We look forward to leveraging our expertise to support Gilead achieve its communication objectives and make a meaningful impact,” she added.
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world.
